An Exploratory Pilot Study of Nab-paclitaxel Based Induction Chemotherapy Followed by Response-Stratified Locoregional Therapy for Patients With Stage III and IV HPV-Related Oropharyngeal Cancer - the OPTIMA HPV Trial
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 14 Sep 2017
At a glance
- Drugs Paclitaxel (Primary) ; Carboplatin; Cisplatin; Fluorouracil; Hydroxycarbamide
- Indications Human papillomavirus infections; Oropharyngeal cancer
- Focus Therapeutic Use
- Acronyms OPTIMA
- 08 Sep 2017 Planned End Date changed from 1 Aug 2017 to 1 Jun 2018.
- 08 Sep 2017 Planned primary completion date changed from 1 Aug 2017 to 1 May 2018.
- 10 Jun 2017 Biomarkers information updated